Description
Bowel/colon cancer is a major cause of cancer related morbidity worldwide. We will use novel genomic technologies (e.g. CRISPR-Cas12) to perform unbiased parallel combinatorial screen to identify synthetic lethality and druggable combinatorial approaches to inhibit colorectal cancer growth and progression
Essential criteria:
Minimum entry requirements can be found here: https://www.monash.edu/admissions/entry-requirements/minimum
Keywords
genetics, genomics, cancer, screen, personalised medicine
School
School of Clinical Sciences at Monash Health / Hudson Institute of Medical Research » Molecular and Translational Sciences
Available options
PhD/Doctorate
Masters by research
Honours
Time commitment
Full-time
Top-up scholarship funding available
Yes
Year 1:
$3000
Physical location
Monash Health Translation Precinct (Monash Medical Centre)
Co-supervisors
Dr
Chunhua Wan